Synergistic Inhibition of Nav1.7 and NCX1: A Novel Strategy for Treating Cancer-Induced Bone Pain by Modulating Pain Sensitization and Neuronal Inflammation. [PDF]
Feng Y +9 more
europepmc +1 more source
Sodium channels as a new target for pain treatment. [PDF]
Chen R +6 more
europepmc +1 more source
Targeting Na<sub>v</sub>1.8 with the nonopioid antagonist suzetrigine for analgesia: cause for optimism? [PDF]
Attal N, Barrot M.
europepmc +1 more source
Preorganized Electric Fields in Voltage-Gated Sodium Channels. [PDF]
Zheng Y, Chen T, Vaissier Welborn V.
europepmc +1 more source
Gene Therapy and Epigenetic Modulation in Chronic Pain: A Future Without Opioids? [PDF]
Idahor CO +8 more
europepmc +1 more source
A high-resolution genomic roadmap for chronic pain converges on glutamatergic neurons and C-fibers. [PDF]
RodrÃguez-Palma EJ, Khanna R.
europepmc +1 more source
Deciphering the Structural and Functional Effects of the R1150W Non-Synonymous Variant in SCN9A Linked to Altered Pain Perception. [PDF]
Al-Allaf FA, Abduljaleel Z, Athar M.
europepmc +1 more source
Pharmacological targeting and characterization of Voltage-Gated Sodium Channels (VGSCs) expressed in the high-grade glioma microenvironment. [PDF]
Fletcher EV +22 more
europepmc +1 more source
Sculpting excitable membranes: voltage-gated ion channel delivery and distribution. [PDF]
Tyagi S +4 more
europepmc +1 more source
Modulation of human dorsal root ganglion neuron firing by the Nav1.8 inhibitor suzetrigine. [PDF]
Stewart RG +6 more
europepmc +1 more source

